Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec;10(6):778-782.
doi: 10.1093/ckj/sfx066. Epub 2017 Aug 29.

Renal denervation using carbon dioxide renal angiography in patients with uncontrolled hypertension and moderate to severe chronic kidney disease

Mohammed Awais Hameed  1   2 , Jonathan S Freedman  2 , Richard Watkin  2 , Arul Ganeshan  2 , Indranil Dasgupta  2   3
Affiliations

Renal denervation using carbon dioxide renal angiography in patients with uncontrolled hypertension and moderate to severe chronic kidney disease

Mohammed Awais Hameed et al. Clin Kidney J. 2017 Dec.

Abstract

Background: Chronic kidney disease (CKD) is the most common cause of secondary hypertension. More than half of the patients have uncontrolled hypertension (≥140/90 mmHg on three or more antihypertensive agents at optimum doses). Renal sympathetic denervation (RSDN) has been shown to reduce blood pressure (BP) in patients with resistant hypertension. Although patients with CKD have high sympathetic drive, all major clinical trials have excluded patients with estimated glomerular filtration rates (eGFRs) <45 mL/min/1.73m2 for risk of contrast-induced nephropathy.

Methods: In this pilot study, carbon dioxide (CO2) was used as the sole contrast agent to carry out renal angiography and RSDN in patients with moderate to severe CKD (eGFR 15-44 mL/min/1.73m2) and uncontrolled hypertension.

Results: Eleven patients (eight males) underwent RSDN. The median age was 57 years [interquartile range (IQR) 49-66]. The median number of antihypertensives being taken at baseline was 4 (IQR 3-4). No statistically significant difference was observed in serum creatinine in the serial follow-ups until at 6 months[median difference 0.25 mg/dL (IQR 0.09-0.53); P = 0.008]. There was a non-significant reduction in median clinic BP from baseline to 6 months [-14 mmHg (IQR -24-5)] and a significant increase in daytime ambulatory systolic BP [7 mmHg (IQR -2-12); P= 0.045]. A trend towards a serial reduction in albuminuria was observed. Procedure-related complications included a groin haematoma (n = 1) and reported flank (n = 1) and groin pain (n = 1).

Conclusions: This pilot study shows that CO2 renal angiography can be used to perform RSDN in patients with significant renal impairment and may lead to associated improvements in clinic BP and albuminuria.

Keywords: carbon dioxide angiography; chronic kidney disease (CKD); contrast nephropathy, renal sympathetic denervation; uncontrolled hypertension.

PubMed Disclaimer

References

    1. Muntner P, Anderson A, Charleston J. et al. Hypertension awareness, treatment, and control in adults with CKD: results from the chronic renal insufficiency cohort (CRIC) study. Am J Kidney Dis 2010; 55: 441–451 - PMC - PubMed
    1. Mahmoodi BK, Matsushita K, Woodward M. et al. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet 2012; 380: 1649–1661 - PMC - PubMed
    1. Sag AA, Covic A, London G. et al. Clinical imaging of vascular disease in chronic kidney disease. Int Urol Nephrol 2016; 48: 827–837 - PubMed
    1. Bakris GL, Williams M, Dworkin L. et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. Am J Kidney Dis 2000; 36: 646–661 - PubMed
    1. Sag AA, Sos TA, Benli C. et al. Atherosclerotic renal artery stenosis in the post-CORAL era part 2: new directions in transcatheter nephron salvage following flawed revascularization trials. J Am Soc Hypertens 2016; 10: 368–377 - PubMed